ArticleBMJ open2024

Identifying thresholds for meaningful improvements in NTDT-PRO scores to support conclusions about treatment benefit in clinical studies of patients with non-transfusion-dependent beta-thalassaemia: analysis of pooled data from a phase 2, double-blind, placebo-controlled, randomised trial.

Ali T Taher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.